Alexandros Makriyannis, Ph.D.

Director, Center for Drug Discovery


Dear Colleagues,

It gives me great pleasure to invite you to the 2nd Annual Chemistry & Pharmacology of Drugs of Abuse Conference, August 10th-11th, 2017 at Northeastern University in Boston, Massachusetts. This two-day meeting is supported in part by the National Institute on Drug Abuse (NIDA) for the purpose of presenting, educating about, and discussing frontline topics in the medicinal chemistry and pharmacology of drug-abuse research.  The participation of scientists from academia, NIDA as well as the biotech industry is expected.  In addition, NIDA administrators will be available for consultation regarding funding opportunities. 

Given the unmet medical needs associated with substance-use disorders (SUDs), a prominent focus will be medicinal chemistry approaches that have the potential to generate new and effective SUD pharmaco-therapeutics and experimental tools for investigating abuse-related pharmacology and pathology in vitro and in vivo. An important component of such an effort involves the generation of new chemical entities and their pharmacological profiling in relevant addiction models and the formulation and validation of appropriate experimental paradigms that have translational significance.

A related program topic considers ways in which medicinal chemistry can inform our understanding of the pathological mechanisms underlying drug addiction and the pharmacological underpinnings of potential treatment approaches through, for instance, generating new molecular imaging probes and ligands that can help identify and annotate new SUD drug targets of therapeutic relevance. These programmatic subjects would further shed light on specific mechanisms of molecular pharmacology that could be potentially leveraged and optimized for therapeutic gain against drug addiction.

The conference will provide a unique opportunity to integrate very recent laboratory findings in medicinal chemistry with the pharmacology and pathological mechanisms underlying addiction and the search for effective pharmacotherapies to treat substance use disorders.  The meeting will also provide a venue to graduate students, postdoctoral fellows and junior scientists to be exposed to current aspects of drug abuse research and opportunities to engage in collaborations.

Space is limited, and we urge you to Register soon.

We look forward to seeing you in June!

Best regards,

‚ÄčAlexandros Makriyannis